» Articles » PMID: 2031869

Propionyl-L-carnitine: Biochemical Significance and Possible Role in Cardiac Metabolism

Overview
Date 1991 Feb 1
PMID 2031869
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Propionyl-CoA is formed principally during amino acid catabolism. It is then converted chiefly to succinate in a described three-step sequence. Free propionate is formed from propionyl-CoA to a very limited extent, but this anion can participate in a futile cycle of activation and hydrolysis, which can significantly deplete mitochondrial ATP. Free CoA and propionyl-CoA cannot enter or leave mitochondria, but propionyl groups are transferred between separate CoA pools by prior conversion to propionyl-L-carnitine. This reaction requires carnitine and carnitine acetyl transferase, an enzyme abundant in heart tissue. Propionyl-L-carnitine traverses both mitochondrial and cell membranes. Within the cell, this mobility helps to maintain the mitochondrial acyl-CoA/CoA ratio. When this ratio is increased, as in carnitine deficiency states, deleterious consequences ensue, which include deficient metabolism of fatty acids and urea synthesis. From outside the cell (in blood plasma), propionyl-L-carnitine can either be excreted in the urine or redistributed by entering other tissues. This process apparently occurs-without prior hydrolysis and reformation. It is suggested that heart tissue utilizes such exogenous propionyl-L-carnitine to stimulate the tricarboxylic acid cycle (via succinate synthesis) and that this may explain its known protective effect against ischemia.

Citing Articles

Plasma Levels of Propionylcarnitine Improved Prediction of Heart Failure and All-Cause Mortality in Patients with Stable Coronary Artery Disease.

Lumpuy-Castillo J, Ruperez F, Porto B, Cristobal C, Tarin N, Huelmos A Biomolecules. 2025; 15(1).

PMID: 39858422 PMC: 11764408. DOI: 10.3390/biom15010027.


Liver sinusoidal endothelial cells rely on oxidative phosphorylation but avoid processing long-chain fatty acids in their mitochondria.

Kaczara P, Czyzynska-Cichon I, Kus E, Kurpinska A, Olkowicz M, Wojnar-Lason K Cell Mol Biol Lett. 2024; 29(1):67.

PMID: 38724891 PMC: 11084093. DOI: 10.1186/s11658-024-00584-8.


Carnitines as Mitochondrial Modulators of Oocyte and Embryo Bioenergetics.

Placidi M, Emidio G, Virmani A, DAlfonso A, Artini P, DAlessandro A Antioxidants (Basel). 2022; 11(4).

PMID: 35453430 PMC: 9024607. DOI: 10.3390/antiox11040745.


Medical and nutritional implications in chronic heart failure: strengths and limitations.

Rosa L, Robledo-Valdez M, Cervantes-Perez E, Cervantes-Guevara G, Cervantes-Cardona G, Ramirez-Ochoa S Arch Cardiol Mex. 2021; 91(2):221-228.

PMID: 33887757 PMC: 8295859. DOI: 10.24875/ACM.20000260.


A Mitochondrial Polymorphism Alters Immune Cell Metabolism and Protects Mice from Skin Inflammation.

Schilf P, Kunstner A, Olbrich M, Waschina S, Fuchs B, Galuska C Int J Mol Sci. 2021; 22(3).

PMID: 33498298 PMC: 7863969. DOI: 10.3390/ijms22031006.


References
1.
Liedtke A, Demaison L, Nellis S . Effects of L-propionylcarnitine on mechanical recovery during reflow in intact hearts. Am J Physiol. 1988; 255(1 Pt 2):H169-76. DOI: 10.1152/ajpheart.1988.255.1.H169. View

2.
Lee S, Davis E . Amino acid catabolism by perfused rat hindquarter. The metabolic fates of valine. Biochem J. 1986; 233(3):621-30. PMC: 1153077. DOI: 10.1042/bj2330621. View

3.
Stumpf D, McAfee J, Parks J, EGUREN L . Propionate inhibition of succinate:CoA ligase (GDP) and the citric acid cycle in mitochondria. Pediatr Res. 1980; 14(10):1127-31. DOI: 10.1203/00006450-198010000-00008. View

4.
CIMAN M, Rossi C, SILIPRANDI N . On the mechanism of the antiketogenic action of propionate and succinate in isolated rat liver mitochondria. FEBS Lett. 1972; 22(1):8-10. DOI: 10.1016/0014-5793(72)80205-9. View

5.
Sherry A, Malloy C, Roby R, Rajagopal A, Jeffrey F . Propionate metabolism in the rat heart by 13C n.m.r. spectroscopy. Biochem J. 1988; 254(2):593-8. PMC: 1135119. DOI: 10.1042/bj2540593. View